History of Strategic Acquisitions
TAPI is a unit of Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer and one of the 15 largest pharmaceutical companies worldwide.
The rich history of the TAPI Division dates back to 1935 with the founding of Assia, a company that specialized in the production of veterinary and pharmaceutical ingredients.
TAPI has grown by acquiring and establishing top-rated manufacturing and development facilities around the world. The already high-quality standards of each acquired plant are fully synchronized with TAPI best practices through a comprehensive integration program.
At the heart of TAPI lies the Israel-based Teva-Tech plant, a state-of the-art facility established in 1995 with numerous dedicated high-volume production areas. Today TAPI operates 19 production plants and 7 R&D centers across the globe. Each facility contributes to our accumulated knowledge and ongoing excellence in R&D, production and customer service, all of which benefit our customers.